Explore more publications!

Helios Fairfax Partners Corporation Closes Amendment to Credit Facility

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (“Helios Fairfax”) (TSX: HFPC.U) announces that it has closed an amendment and restatement of its existing credit facility with FirstRand Bank Limited (acting through its Rand Merchant Bank division) (the “Amended Credit Facility”). The key modifications to the Amended Credit Facility include the following:

  • Facility Increase: The lenders have increased their commitments on the secured revolving credit facility to US$85 million, with an option for Helios Fairfax to request an additional increase of US$15 million.
  • Purpose: The secured revolving credit facility is to be used for the purpose of (a) making investments in accordance with Helios Fairfax’s investment objectives and investment restrictions; and (b) for general corporate purposes.
  • Updated Financial Covenants: Revised covenants which provide Helios Fairfax with the flexibility to support its investment strategy.
  • Term: Five years from the closing date of the Amended Credit Facility.

Helios Fairfax is an investment holding company whose investment objective is to achieve long term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in Africa and African businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, Africa.

For further information, contact:  Neil Weber, LodeRock Advisors
  (neil.weber@loderockadvisors.com)
  (647) 222-0574

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions